![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-in-the-dubermatinib-arm-of-the-leukemia--lymphoma-societys-beat-aml-master-clinical-trial-in-patients-with-acute-myeloid-leukemia-301158414.html
https://www.biospace.com/article/releases/sumitomo-dainippon-pharma-oncology-presents-findings-from-phase-1-clinical-study-evaluating-investigational-agent-dubermatinib-in-patients-with-advanced-solid-tumors-at-esmo-2020-virtual-annual-congress/